Trial NCT02437162

View at ClinicalTrials.gov 
Org. Study IDs: CR107098
Secondary IDs: 2014-003679-48 CNTO1275AKS3001

Last trial update was posted on 2019-08-28

MeSH Interventions

Golimumab Ustekinumab

MeSH Conditions

Axial Spondyloarthritis Spondylarthritis Spondylitis

Other Conditions


Stopping Reasons

Neither dose achieved the study's primary or major secondary endpoints. The safety profile was consistent with previous ustekinumab studies.

Limitations And Caveats

The study was terminated since neither dose achieved the study's primary or major secondary endpoints.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID